Neonatal renal vein thrombosis: Role of anticoagulation and thrombolysis—An institutional review

ABSTRACT Neonatal renal vein thrombosis (NRVT) is a rare thromboembolic complication in the neonatal period, and sequelae from renal dysfunction can cause significant morbidity. The authors retrospectively reviewed 10 patients with NRVT treated at their institution. The majority of the cohort were male (n = 9), preterm (n = 6), and had unilateral NRVT (n = 6). Six patients received thrombolysis and/or anticoagulation, and 4 patients received supportive care only. Two of the 6 patients treated with anticoagulation who had bilateral NRVT and anuria received thrombolysis with low-dose tissue plasminogen activator. Thrombolysis was not associated with any major adverse events, and both patients had marked improvement of renal function. Eight patients subsequently developed renal atrophy (3 received anticoagulation, 2 received thrombolysis with anticoagulation, and 3 received supportive care). Anticoagulation/thrombolysis did not appear to prevent renal atrophy. The role of thrombolysis needs to be further studied and considered in the setting of bilateral NRVT and acute renal failure.

[1]  S. Vesely,et al.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[2]  L. Brandão,et al.  Neonatal renal vein thrombosis. , 2011, Seminars in fetal & neonatal medicine.

[3]  R. Ljung,et al.  Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC , 2009, Pediatric Nephrology.

[4]  L. Brandão,et al.  Neonatal Renal Vein Thrombosis: Review of the English-Language Literature Between 1992 and 2006 , 2007, Pediatrics.

[5]  A. Sinaiko,et al.  Renal Outcome of Neonatal Renal Venous Thrombosis: Review of 28 Patients and Effectiveness of Fibrinolytics and Heparin in 10 Patients , 2006, Pediatrics.

[6]  A. Wade,et al.  Perinatal renal venous thrombosis: presenting renal length predicts outcome , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[7]  N. Rosenblum,et al.  Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. , 2005, The Journal of pediatrics.

[8]  K. Kurnik,et al.  Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. , 2004, Blood.

[9]  S. Kuhle,et al.  A case series of 72 neonates with renal vein thrombosis , 2004, Thrombosis and Haemostasis.

[10]  L. Valentino,et al.  Low-Dose Tissue Plasminogen Activator Thrombolysis in Children , 2003, Journal of pediatric hematology/oncology.

[11]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study , 2000, British journal of haematology.

[12]  S. Emil,et al.  Renal vein thrombosis: a 10-year review. , 2000, Journal of pediatric surgery.

[13]  R. von Kries,et al.  Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome , 2000, European Journal of Pediatrics.

[14]  G. Sebag,et al.  Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. , 1998, The Journal of pediatrics.

[15]  A. Berghold,et al.  Intracerebral Hemorrhage During Fibrinolytic Therapy in Children: A Review of the Literature of the Last Thirty Years , 1997, Seminars in thrombosis and hemostasis.

[16]  B. Schmidt,et al.  Neonatal thrombosis: report of a prospective Canadian and international registry. , 1995, Pediatrics.

[17]  M. Ricci,et al.  Renal venous thrombosis in infants and children. , 1990, Archives of surgery.

[18]  J. Jobin,et al.  Neonatal renal vein thrombosis - long-term follow-up after conservative management. , 1982, Clinical nephrology.

[19]  L. Martin,et al.  Natural history and treatment of renal vein thrombosis in children. , 1977, Journal of pediatric surgery.